Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-24

Clinical Trial Update: Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating hydroxychloroquine for hidradenitis suppurativa has completed Phase 1 and Phase 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Elena Gonzalez Brant, MD | Conditions: Hidradenitis Suppurativa, Hidradenitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-03-24